A case for the use of receiver operating characteristic analysis of potential clinical efficacy biomarkers in advanced renal cell carcinoma

AIM: Assess patient-level utility of suggested pretreatment biomarkers of sunitinib in advanced renal cell carcinoma. PATIENTS & METHODS: Kaplan–Meier analysis of data from a randomized, Phase II study (n = 292) suggested baseline predictive value for circulating soluble Ang-2 and MMP-2 and HIF-...

Descripción completa

Detalles Bibliográficos
Autores principales: English, Patricia A, Williams, J Andrew, Martini, Jean-François, Motzer, Robert J, Valota, Olga, Buller, Richard E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549778/
https://www.ncbi.nlm.nih.gov/pubmed/26674983
http://dx.doi.org/10.2217/fon.15.290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549778/
https://www.ncbi.nlm.nih.gov/pubmed/26674983
http://dx.doi.org/10.2217/fon.15.290

Ejemplares similares